Recently, two alternative transcription start sites for the ACSS2 gene have been identified in hepatocellular carcinoma cells that may help explain the dual role of ACSS2 in promoting and inhibiting cancer aggressiveness (Wang et al., 2019). This evidence concerns the gene ACSS2 and hepatocellular carcinoma.